Anti-atherosclerotic use of 17 alpha-dihydroequilin

Details Anti-atherosclerotic use of 17 alpha-dihydroequilin Anti-atherosclerotic use of 17 alpha-dihydroequilin

1993-12-01

1996-01-09

Jordan, Kimberly R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514824, A61K 3156

Patent

active

054829356

ABSTRACT:
A method for the treatment of atherosclerosis by administering to a patient in need of anti-atherosclerotic treatment, an effective amount of 17 alpha-dihydroequilin, a C.sub.2 -C.sub.6 alkanoyloxy ester thereof or a pharmaceutically acceptable salt of it's sulfate or phosphate ester, in the absence of naturally occurring estrogenic sreroids. A pharmaceutical composition containing 17 alpha-dihydroequilin, a C.sub.2 -C.sub.6 alkanoyloxy ester thereof or a pharmaceutically acceptable salt of it's sulfate or phosphate ester, in the absence of naturally occurring estrogenic sreroids, and a pharmaceutically acceptable carrier therefor.

REFERENCES:
patent: 4154820 (1979-05-01), Simoons
CA 111:17923, Sonnendecker et al., 1989.
Levy, R., Am. Heart J. 110: 1116 (1985).
Ross, R., New Eng. J. Med. 295:369 (1977).
Ross, R., New Eng. J. Med. 314:488 (1986).
Manderson, J. A., Arteriosclerosis 9:289 (1989).
Clowes, A. W., Circ. Res. 56:139 (1985).
Clowes, W. W., J. Cardiovas. Pharm. 14 (Suppl 6):S12 (1989).
Barrett-Connor, E., JAMA 265: (1991).
Chao, Y.-S., J. Biol. Chem. 254:11360 (1979).
Kovanen, P. T., J. Biol. Chem. 254: 11367 (1979).
Windler E. E. T., J. Biol. Chem., 255: 10464 (1980).
Stampfer, M. L., New Eng. J. Med. 313: 1044 (1985).
Utian, W. H., Obstet. Gynecol. Surv. 32: 193 (1977).
ACOG Technical Bulletin 93: 1 (1986).
Hammond, C. B., Fertil. Steril. 37:5 (1982).
Whitehead, M. I., Am. J. Obstet. Gynecol. 142:791 (1982).
Gambrell, R. D., South Med. J. 71:1280 (1978).
McDonald T. W., Am. J. Obstet. Gynecol. 127:572 (1977).
Whitehead, M. I., J. R. Soc. Med. 72:322 (1979).
Barrett-Connor, E. Annu. Rev. Med. 43:239 (1992).
Howard, et al., Arch Int. Med. 128:229 (1971).
Stern, Maturitas 4:333 (1982).

Affiliated with

Also associated with

Rating

Anti-atherosclerotic use of 17 alpha-dihydroequilin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-atherosclerotic use of 17 alpha-dihydroequilin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-atherosclerotic use of 17 alpha-dihydroequilin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1303235